|
INCREASING BUTYRATE LEVELS BY MICROBIOME MANIPULATION OR DRUG ADMINISTRATION TO DELAY PARKINSONS DISEASE PROGRESSION. |
1F31AT010095-01 |
GARCIA, STEPHANIE MICHELLE |
NCCIH |
2018 |
|
IMPACT OF FOOD-DERIVED POLYPHENOLS ON DOPAMINE NEURONS IN THE AGED BRAIN |
1R21AT009604-01A1 |
SMITH, AMANDA D |
NCCIH |
2018 |
|
IDENTIFICATION OF NOVEL INHIBITORS OF OCULAR NEOVASCULARIZATION |
1R21EY028701-01 |
FERRARA, NAPOLEONE |
NEI |
2018 |
|
FIBROSIS-FREE GLAUCOMA DRAINAGE IMPLANTS |
1R21EY028747-01 |
XIE, CHONG |
NEI |
2018 |
|
AQUAPORIN-4 IN NMO OPTIC NEURITIS: PATHOGENESIS AND NEW THERAPIES |
3R01EY013574-16S1 |
VERKMAN, ALAN S |
NEI |
2018 |
|
MECHANISMS OF ACTIVITY-DEPENDENT MYELINATION IN THE VISUAL SYSTEM |
3R01EY025687-04S1 |
DESILVA, TARA MARIA |
NEI |
2018 |
|
PATHOGENIC ROLE OF EPAC1 SIGNALING IN RETINOPATHY OF PREMATURITY |
3R01EY026629-02S1 |
ZHANG, WENBO |
NEI |
2018 |
|
DE-RISKING ONL1204 TO ENABLE VENTURE CAPITAL INVESTMENT FOR FIRST-IN-HUMAN CLINICAL TRIALS |
3SB1EY022512-04S1 |
VAN DE GOOR, JANA |
NEI |
2018 |
|
MICROGLIAL ACTIVATION DURING PHOTORECEPTOR DEGENERATION |
5R01EY024320-04 |
BURNS, MARIE E |
NEI |
2018 |
|
ACTIVATION OF THE ANGIOPOIETIN-TIE2 PATHWAY TO TREAT OCULAR HYPERTENSION AND GLAUCOMA |
5R01EY025799-03 |
QUAGGIN, SUSAN E. |
NEI |
2018 |